This month we take an indepth look at diabetes, examining its healthcare implications, highlighting some examples of good practice from HCPs in the UK and looking at how behavioural economics could help when it comes to adherence.
Our diabetes theme continues as we look at biosimilars and the winding regulatory pathway they must follow as authorities work out how to apply their assessment criteria to this still relatively new area.
We hear from Celgene’s Tuomo Pätsi about company culture, marketing and access – the latter of which he says is the role of everyone at his company.
In our cover feature – A Sharper Focus – Professor Brian Smith asks how a highly-effective brand team differs from the industry standard?
This month’s PME also has the latest Heart of the Matter supplement, produced in association with McCann Complete Medical, which this month tackles innovation.
And in 10 Ways … to meet event disclosure rules, Ashfield Meetings & Events provide a practice guide to the forthcoming European rule changes on pharma to healthcare professional/organisation spending.
The November issue and its supplements are available to view online now, but if you don’t currently receive PME on a regular basis you can subscribe to the print or digital edition – or keep up with pharma news on a more regular basis via our PMLiVE Daily or Weekly email newsletters.
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone, iPad, Android and Kindle Fire
